Cerebrovascular disease with antiphospholipid antibodies: Immune mechanisms, significance, and therapeutic options
- 1 May 1995
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 37 (S1), 114-130
- https://doi.org/10.1002/ana.410370712
Abstract
There has been a recent, dramatic surge in interest in antiphospholipid antibodies and associated clinical disorders, especially focal ischemic cerebrovascular disease. Antiphospholipid antibodies are a heterogeneous group of antibodies with varying specificities. Coagulation assays will detect lupus anticoagulants while enzyme-linked immunosorbent assays detect anticardiolipin antibodies. There are numerous potential links between antiphospholipid antibodies and coagulation disorders, including interaction of antiphospholipid antibodies and a cofactor, β2–glycoprotein I, which itself is involved in coagulation mechanisms. While the specific mechanism of antiphospholipid antibody-related coagulopathy is unknown, it is clear that antiphospholipid antibodies are associated with an immune-mediated prothrombotic state. Patients with the highest titers of IgG antiphospholipid antibodies have a relatively high risk of recurrent thrombotic events, especially stroke, deep venous thrombosis, and spontaneous abortion. Because of limited controlled, prospective data, current therapy remains empiric and directed at coagulation mechanisms, immune mechanisms, or both.Keywords
This publication has 97 references indexed in Scilit:
- Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human β2 glycoprotein 1 or anticardiolipin antibodies aloneClinical and Experimental Immunology, 1993
- Specific Antiphospholipid Antibodies as a Predictive Variable in Patients With Recurrent Pregnancy LossAmerican Journal of Reproductive Immunology, 1993
- Lupus‐like anticoagulant properties of murine monoclonal antibodies to β2‐glycoprotein IBritish Journal of Haematology, 1992
- Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodiesBritish Journal of Haematology, 1991
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- Cardiogenic brain embolism and lupus anticoagulantAnnals of Neurology, 1989
- INTRAVENOUS GAMMAGLOBULIN, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOCYTOPENIAThe Lancet, 1988
- An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two casesArthritis & Rheumatism, 1987
- Obstetric Complications Associated with the Lupus AnticoagulantNew England Journal of Medicine, 1985
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981